As shown in Fig. 1d, CD276 CAR-T was highly effective against multiple pancreatic cancer cell lines at different E: T ratio while the killing efficiency was low in eradicating hematologic tumor cell lines, indicating a CD276-specific cytotoxicity. This evidence concerns the gene CD276 and familial pancreatic carcinoma.